Zhejiang Wolwo Bio Pharmaceutical Co Ltd operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Wolwo Bio Pharmaceutical Co Ltd with three other
pharmaceutical manufacturers in Asia:
Cell Biotech Co ., Limited.
of South Korea
sales of 61.06 billion Korean Won [US$57.03 million]
of which 88%
was Finished Products),
Pharma Foods International Co.Ltd
(4.72 billion Japanese Yen [US$44.11 million]
of which 73%
was Functional product(Online business)), and
Panacea Biotec Ltd
based in India
(5.39 billion Indian Rupees [US$82.25 million]
of which 69%
Zhejiang Wolwo Bio Pharmaceutical Co Ltd reported sales of 385.58 million Chinese Renmimbi (US$61.43 million)
December of 2017.
increase of 23.5%
versus 2016, when the company's sales were 312.09 million Chinese Renmimbi.
Sales at Zhejiang Wolwo Bio Pharmaceutical Co Ltd have increased during each of the previous five years
(and since 2012, sales have increased a total of 161%).